Kabara Cancer Research Institute

Advancing the science of Precision Oncology.

Led by Dr. Paraic Kenny, our team applies genomics, molecular biology, and translational research to drive advances in solid tumor oncology — from biobank-scale discovery to clinical precision medicine.

Lab Research

Ongoing Impact

Managing the Gundersen Cancer Biobank with 140,000+ specimens.

Core Research Focus

Functional Genomics

Utilizing high-throughput genomic sequencing to identify novel drivers in solid tumor development.

Learn more

Precision Oncology

Contributing to Wisconsin's Molecular Tumor Board to translate data into life-saving clinical decisions.

Clinical work

Specimen Biobanking

The KCRI houses the CAP-accredited Gundersen Cancer Biobank with over 140,000 specimens.

Biobank access